arrow
S

Satoshi Miyata

Teikyo University
H指数:59
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cutting vs standard balloon for lesion preparation in drug-coated balloon-only PCI: the NATURE randomised trial

药物涂层球囊仅PCI中病变准备采用切割球囊与标准球囊的比较:NATURE随机试验

2026-08-250
OA
Association of reduced Cu,Zn-superoxide dismutase with coronary microvascular dysfunction-An observational study of oxidative stress markers-

还原的Cu,Zn-超氧化物歧化酶与冠状动脉微血管功能障碍的关联——一项氧化应激标志物的观察性研究

2026-05-230
OAAI
Risk Prediction Models of Cardiotoxicity in Patients with Breast Cancer Multicenter Prospective CHECK HEART-BC Study
2026-02-013
OAAI
Cutting balloon versus standard balloon for lesion preparation of drug-coated balloon treatment in de-novo coronary artery lesions: Rationale and design of the randomized NATURE trial

切割球囊与标准球囊用于新发冠状动脉病变药物涂层球囊治疗的病变准备:NATURE随机试验的原理与设计

2025-12-010
PRE
Long-Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

结缔组织病相关肺动脉高压患者接受强化免疫抑制治疗的长期预后及血流动力学结局

2025-10-011
OAAI
New-onset anemia and its association with ventricular arrhythmias and sudden cardiac death in patients with heart failure with preserved ejection fraction

新发贫血及其与射血分数保留的心力衰竭患者室性心律失常和心源性猝死的关系

2025-09-250
PREAI
Association of a mild or an important decline in left ventricular ejection fraction with ventricular tachyarrhythmias, sudden cardiac death and all-cause death in heart failure with preserved ejection fraction: A report from the CHART-2 Study
2025-08-290
OA
CTRP7 as a molecular biomarker associating with responsiveness to pulmonary vasodilators: insights from human and animal studies in pulmonary arterial hypertension

CTRP7作为与肺血管扩张剂反应性相关的分子生物标志物:来自肺动脉高压人类和动物研究的见解

2025-05-010
OAAI
Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

心力衰竭伴超正常左心室射血分数的临床与血浆蛋白质组学特征:心力衰竭的一种新兴实体

2025-04-013
OAAI